Vienna, Austria

Shushan Harutyunyan

This inventor holds 1 USPTO granted patent. Top assignee: Cebina Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shushan Harutyunyan. Retrieved from https://idiyas.com/inventor/shushan-harutyunyan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shushan Harutyunyan: Innovator in Vaccine Development

Introduction

Shushan Harutyunyan is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of vaccine development, particularly with his innovative work on a high-dose Shigella vaccine preparation. His dedication to advancing medical science is evident through his research and patent achievements.

Latest Patents

Shushan holds a patent for a HIGH DOSE SHIGELLA VACCINE PREPARATION. This patent represents a crucial step in the fight against Shigellosis, a disease caused by Shigella bacteria, which can lead to severe gastrointestinal issues. His work in this area showcases his commitment to improving public health.

Career Highlights

Shushan is currently employed at Cebina GmbH, a company focused on biopharmaceuticals and vaccine development. His role at Cebina allows him to collaborate with other experts in the field, further enhancing his contributions to medical research.

Collaborations

Shushan has worked alongside talented colleagues, including Tamás Henics and Petra Girardi. Their combined expertise fosters a collaborative environment that drives innovation and progress in vaccine research.

Conclusion

Shushan Harutyunyan's work exemplifies the spirit of innovation in the medical field. His contributions, particularly in vaccine development, are vital for addressing public health challenges. His achievements reflect a commitment to advancing science and improving lives through effective medical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…